US Stock MarketDetailed Quotes

Artiva Biotherapeutics (ARTV)

Watchlist
  • 7.990
  • +0.150+1.91%
Close May 21 16:00 ET
  • 8.151
  • +0.161+2.02%
Post 16:02 ET
388.22MMarket Cap-2.25P/E (TTM)

Artiva Biotherapeutics (ARTV) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-5.59%-20.95M
-39.47%-76.75M
-0.52%-14.73M
-65.37%-19.2M
-67.94%-22.98M
-31.52%-19.84M
-16.03%-55.03M
-37.24%-14.65M
-8.03%-11.61M
-16.33%-13.69M
Net income from continuing operations
-15.78%-23.52M
-28.29%-83.87M
-29.06%-20.77M
-23.21%-21.53M
-19.12%-21.25M
-45.46%-20.31M
-127.62%-65.37M
-34.15%-16.1M
-254.91%-17.47M
-58.13%-17.84M
Operating gains losses
----
----
----
----
----
----
408.77%3.6M
--0
--977K
--2.35M
Depreciation and amortization
6.05%666K
6.83%2.6M
8.47%666K
5.58%662K
6.30%641K
6.98%628K
7.28%2.43M
3.37%614K
12.77%627K
12.08%603K
Change In working capital
134.03%506K
-30.46%-424K
1,412.54%4.08M
-87.01%391K
-48,614.29%-3.41M
50.70%-1.49M
98.85%-325K
71.39%-311K
112.65%3.01M
99.80%-7K
-Change in receivables
176.14%67K
-95.10%79K
-97.84%12K
-106.45%-49K
-22.14%204K
-351.43%-88K
230.63%1.61M
-67.66%555K
231.26%760K
116.91%262K
-Change in prepaid assets
451.07%2.63M
21.93%-1.53M
971.59%1.89M
112.92%194K
-1,067.57%-2.86M
19.87%-750K
-480.81%-1.97M
-19.27%176K
-94.43%-1.5M
-77.39%296K
-Change in payables and accrued expense
-146.18%-2.19M
987.86%1.24M
306.24%2.22M
-82.21%677K
-11.45%-759K
59.38%-890K
89.39%-140K
39.63%-1.07M
210.19%3.81M
53.74%-681K
-Change in other current assets
--0
-252.80%-191K
-229.03%-40K
-1,287.50%-380K
-180.65%-25K
719.35%254K
-10.07%125K
-31.11%31K
3.23%32K
3.33%31K
-Change in other working capital
76.92%-3K
-148.84%-21K
800.00%9K
42.05%-51K
-60.00%34K
-128.89%-13K
100.16%43K
100.08%1K
99.63%-88K
104.78%85K
Cash from discontinued investing activities
Operating cash flow
-5.59%-20.95M
-39.47%-76.75M
-0.52%-14.73M
-65.37%-19.2M
-67.94%-22.98M
-31.52%-19.84M
-16.03%-55.03M
-37.24%-14.65M
-8.03%-11.61M
-16.33%-13.69M
Investing cash flow
Cash flow from continuing investing activities
53.61%15.32M
152.64%63.41M
1,760.46%16.04M
112.46%16.28M
1,465.75%21.12M
1.93%9.97M
-363.77%-120.46M
63.79%-966K
-26,396.55%-130.63M
106.44%1.35M
Net PPE purchase and sale
52.64%-242K
-302.96%-2.59M
-557.81%-421K
-525.00%-600K
-127.37%-1.06M
-2,738.89%-511K
80.29%-642K
89.94%-64K
46.37%-96K
20.14%-464K
Net investment purchase and sale
48.43%15.56M
155.08%66M
1,924.94%16.46M
112.93%16.88M
1,123.22%22.18M
6.96%10.48M
-427.45%-119.82M
55.61%-902K
-41,470.70%-130.53M
108.90%1.81M
Cash from discontinued investing activities
Investing cash flow
53.61%15.32M
152.64%63.41M
1,760.46%16.04M
112.46%16.28M
1,465.75%21.12M
1.93%9.97M
-363.77%-120.46M
63.79%-966K
-26,396.55%-130.63M
106.44%1.35M
Financing cash flow
Cash flow from continuing financing activities
-146.86%-112K
-99.99%9K
-303.33%-121K
-100.02%-37K
95.54%-72K
239K
565.11%162.23M
-103.12%-30K
599.38%163.87M
-16,260.00%-1.62M
Net issuance payments of debt
0.00%-33K
11.41%-132K
-3.03%-34K
15.79%-32K
57.69%-33K
---33K
---149K
---33K
---38K
---78K
Net common stock issuance
----
--0
--0
----
----
----
1,352,800.00%162.32M
---4.18M
--166.51M
--0
Proceeds from stock option exercised by employees
-51.84%131K
627.45%371K
--0
1,550.00%99K
--0
--272K
410.00%51K
--23K
--6K
--22K
Net other financing activities
---210K
---230K
---87K
96.00%-104K
----
----
----
----
---2.6M
----
Cash from discontinued financing activities
Financing cash flow
-146.86%-112K
-99.99%9K
-303.33%-121K
-100.02%-37K
95.54%-72K
--239K
565.11%162.23M
-103.12%-30K
599.38%163.87M
-16,260.00%-1.62M
Net cash flow
Beginning cash position
-32.92%27.16M
-24.68%40.49M
-53.74%25.97M
-16.16%28.93M
-36.31%30.86M
-24.68%40.49M
-47.69%53.76M
-15.12%56.14M
-36.04%34.51M
-44.08%48.46M
Current changes in cash
40.34%-5.75M
-0.47%-13.33M
107.62%1.19M
-113.68%-2.96M
86.15%-1.93M
-81.58%-9.63M
72.93%-13.27M
-26.37%-15.65M
77.47%21.63M
57.34%-13.95M
End cash Position
-30.61%21.42M
-32.92%27.16M
-32.92%27.16M
-53.74%25.97M
-16.16%28.93M
-36.31%30.86M
-24.68%40.49M
-24.68%40.49M
-15.12%56.14M
-36.04%34.51M
Free cash flow
-4.13%-21.19M
-42.50%-79.34M
-2.94%-15.15M
-69.14%-19.8M
-69.89%-24.04M
-34.75%-20.35M
-9.84%-55.67M
-30.09%-14.71M
-7.14%-11.71M
-14.61%-14.15M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -5.59%-20.95M-39.47%-76.75M-0.52%-14.73M-65.37%-19.2M-67.94%-22.98M-31.52%-19.84M-16.03%-55.03M-37.24%-14.65M-8.03%-11.61M-16.33%-13.69M
Net income from continuing operations -15.78%-23.52M-28.29%-83.87M-29.06%-20.77M-23.21%-21.53M-19.12%-21.25M-45.46%-20.31M-127.62%-65.37M-34.15%-16.1M-254.91%-17.47M-58.13%-17.84M
Operating gains losses ------------------------408.77%3.6M--0--977K--2.35M
Depreciation and amortization 6.05%666K6.83%2.6M8.47%666K5.58%662K6.30%641K6.98%628K7.28%2.43M3.37%614K12.77%627K12.08%603K
Change In working capital 134.03%506K-30.46%-424K1,412.54%4.08M-87.01%391K-48,614.29%-3.41M50.70%-1.49M98.85%-325K71.39%-311K112.65%3.01M99.80%-7K
-Change in receivables 176.14%67K-95.10%79K-97.84%12K-106.45%-49K-22.14%204K-351.43%-88K230.63%1.61M-67.66%555K231.26%760K116.91%262K
-Change in prepaid assets 451.07%2.63M21.93%-1.53M971.59%1.89M112.92%194K-1,067.57%-2.86M19.87%-750K-480.81%-1.97M-19.27%176K-94.43%-1.5M-77.39%296K
-Change in payables and accrued expense -146.18%-2.19M987.86%1.24M306.24%2.22M-82.21%677K-11.45%-759K59.38%-890K89.39%-140K39.63%-1.07M210.19%3.81M53.74%-681K
-Change in other current assets --0-252.80%-191K-229.03%-40K-1,287.50%-380K-180.65%-25K719.35%254K-10.07%125K-31.11%31K3.23%32K3.33%31K
-Change in other working capital 76.92%-3K-148.84%-21K800.00%9K42.05%-51K-60.00%34K-128.89%-13K100.16%43K100.08%1K99.63%-88K104.78%85K
Cash from discontinued investing activities
Operating cash flow -5.59%-20.95M-39.47%-76.75M-0.52%-14.73M-65.37%-19.2M-67.94%-22.98M-31.52%-19.84M-16.03%-55.03M-37.24%-14.65M-8.03%-11.61M-16.33%-13.69M
Investing cash flow
Cash flow from continuing investing activities 53.61%15.32M152.64%63.41M1,760.46%16.04M112.46%16.28M1,465.75%21.12M1.93%9.97M-363.77%-120.46M63.79%-966K-26,396.55%-130.63M106.44%1.35M
Net PPE purchase and sale 52.64%-242K-302.96%-2.59M-557.81%-421K-525.00%-600K-127.37%-1.06M-2,738.89%-511K80.29%-642K89.94%-64K46.37%-96K20.14%-464K
Net investment purchase and sale 48.43%15.56M155.08%66M1,924.94%16.46M112.93%16.88M1,123.22%22.18M6.96%10.48M-427.45%-119.82M55.61%-902K-41,470.70%-130.53M108.90%1.81M
Cash from discontinued investing activities
Investing cash flow 53.61%15.32M152.64%63.41M1,760.46%16.04M112.46%16.28M1,465.75%21.12M1.93%9.97M-363.77%-120.46M63.79%-966K-26,396.55%-130.63M106.44%1.35M
Financing cash flow
Cash flow from continuing financing activities -146.86%-112K-99.99%9K-303.33%-121K-100.02%-37K95.54%-72K239K565.11%162.23M-103.12%-30K599.38%163.87M-16,260.00%-1.62M
Net issuance payments of debt 0.00%-33K11.41%-132K-3.03%-34K15.79%-32K57.69%-33K---33K---149K---33K---38K---78K
Net common stock issuance ------0--0------------1,352,800.00%162.32M---4.18M--166.51M--0
Proceeds from stock option exercised by employees -51.84%131K627.45%371K--01,550.00%99K--0--272K410.00%51K--23K--6K--22K
Net other financing activities ---210K---230K---87K96.00%-104K-------------------2.6M----
Cash from discontinued financing activities
Financing cash flow -146.86%-112K-99.99%9K-303.33%-121K-100.02%-37K95.54%-72K--239K565.11%162.23M-103.12%-30K599.38%163.87M-16,260.00%-1.62M
Net cash flow
Beginning cash position -32.92%27.16M-24.68%40.49M-53.74%25.97M-16.16%28.93M-36.31%30.86M-24.68%40.49M-47.69%53.76M-15.12%56.14M-36.04%34.51M-44.08%48.46M
Current changes in cash 40.34%-5.75M-0.47%-13.33M107.62%1.19M-113.68%-2.96M86.15%-1.93M-81.58%-9.63M72.93%-13.27M-26.37%-15.65M77.47%21.63M57.34%-13.95M
End cash Position -30.61%21.42M-32.92%27.16M-32.92%27.16M-53.74%25.97M-16.16%28.93M-36.31%30.86M-24.68%40.49M-24.68%40.49M-15.12%56.14M-36.04%34.51M
Free cash flow -4.13%-21.19M-42.50%-79.34M-2.94%-15.15M-69.14%-19.8M-69.89%-24.04M-34.75%-20.35M-9.84%-55.67M-30.09%-14.71M-7.14%-11.71M-14.61%-14.15M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Saudi sources, the United States and Iran will hold a new round of talks in Islamabad, the capital of Pakistan, after the end o Show More